According to the latest report published by Credence Research, Inc. “Anti-epileptic Drugs Market – Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global anti-epileptic drugs market was valued at US$ 4.08 Bn in 2016.
Browse the full report Anti-epileptic Drugs Market – Growth, Future Prospects and Competitive Analysis, 2017–2025 report at http://www.credenceresearch.com/report/anti-epileptic-drugs-market
Epilepsy is a disorder that affects the human nervous system. Epilepsy is characterized by repeated episodes of seizures in the patient. Epileptic seizures are caused by disturbance in electrical activity in the brain. Epileptic seizures can occur in any age group and are diagnosed after one or more episodes of the seizures. Epilepsy is the fourth common brain disorder that occurs in all ages. The exact causes of epilepsy are not known, but the major risk factors include brain tumor and brain injuries. Treatment of epilepsy can be done by anti-epileptic drugs and surgery in some cases. Some of the complementary therapies such as ketogenic diets or neural stimulation are also found effective in the treatment of epilepsy.
Anti-epileptic drugs market is segmented based on drug class. Anti-epileptic drugs market is expanding at a healthy pace due to rising awareness of these diseases among the general population. Rising prevalence of epilepsy and increasing demand for the anti-epileptic drugs are the other factors that contribute to the expansion of anti-epileptic drugs market. Furthermore, it has been observed that anti-epileptic drugs market provides enormous opportunities to the manufacturers due to expanding the global economy and increasing per capita GDP.
The complete report is available at http://www.credenceresearch.com/report/anti-epileptic-drugs-market
Other market driving factor includes the development of smartphone app and devices that help in detection of seizures and track medications. For instance, EpDetect is a smartphone application that uses advanced signal processing to detect epileptic seizures. EpDetect differentiates between the normal movement of the patient and movement associated with seizures. If a patient is detected with seizure, then EpDetect will update the caregiver with the status and GPS location of the patient. These type of innovations will stimulate the anti-epileptic drugs market.
Based on geography, the global anti-epileptic drugs market is studied for North America, Europe, Asia Pacific, Latin America and Middle East Africa. In terms of market value, North America is leading the global market and is estimated to retain its dominance throughout the forecast period. Favorable government initiatives and the rapid introduction of new anti-epileptic drugs in the market are the factors contributing to the growth of the market in these countries. There are many drugs available in the market that are approved for epilepsy. Market leaders in the anti-epileptic drugs market are Pfizer, Inc., UCB Pharma, and GlaxoSmithKline Plc.
About Credence Research:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Company Name: Credence Research
Contact Person: Chris Smith, Global Sales Manager
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
Country: United States